Business Context and Reporting Period
Company: BIO-RAD LABORATORIES, INC.
Filing Type: Form 8-K (Current Report)
Date of Report: March 25, 2014
Event: Amendment and restatement of the Company's By-laws by the Board of Directors.
Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is strictly a corporate governance report regarding By-law amendments.
Material Changes
The Board amended the By-laws to update corporate governance procedures. Key changes include:
- Registered Office: Changed from Richmond, California to Hercules, California.
- Annual Meetings: The date is no longer fixed to April; the Board may specify the date and may postpone, reschedule, or cancel meetings. Electronic notice is permitted.
- Voting Procedures:
- Directors are elected by a majority of votes cast (excluding abstentions and broker non-votes). Directors failing to receive a majority must tender resignation, subject to Board acceptance within 90 days.
- Contested elections of directors are decided by a plurality of votes cast.
- Majority voting for non-director matters requires the affirmative vote of a majority of stock having voting power present.
- Stockholder Proposals and Nominations: New sections (15 and 16) establish exclusive procedures for stockholders to bring business or nominate directors, including strict notice requirements and "Solicitation Representation" compliance.
- Forum Selection: Added a provision designating the Court of Chancery of the State of Delaware (or other Delaware courts/federal district court) as the sole and exclusive forum for derivative actions, fiduciary duty claims, and internal affairs disputes.
- Indemnification: Restated provisions to indemnify directors, officers, employees, and agents to the fullest extent permitted by law, including advance payment of expenses.
- Operational Updates: Allowed for electronic consents for Board actions, uncertificated shares, and clarified quorum and waiver of notice rules.
Guidance, Outlook, and Risks
Management Commentary: The filing states that the amendments were made to clarify procedures and align with modern corporate governance standards. No financial guidance or outlook is provided.
Risks and Contingencies: The filing does not disclose new financial risks. The new exclusive forum provision (Section 54) limits the venues for legal actions against the Company, which may affect stockholder litigation rights.
Key Facts for Investor Verification
- Verify the impact of the new "majority voting" standard for directors on Board composition and stability.
- Review the specific notice periods and procedural requirements for stockholders wishing to nominate directors or present business at annual meetings (Sections 15 and 16).
- Confirm the legal enforceability of the exclusive Delaware forum provision for derivative and fiduciary duty claims.
- Note the change in the Company's principal place of business to Hercules, California.